- Research Fellow, Pharmaceutical Sciences, King's College London
Amir Englund works at the Institute of Pharmaceutical Sciences and has a PhD in cannabinoid psychopharmacology. He has conducted several experimental cannabis studies in humans as well as clinical trials exploring the antipsychotic effects of cannabidiol in schizophrenia.
Experience
-
–presentResearch Fellow, King's College London
Contact Amir for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: London, UK
- Website
- X (formerly Twitter): @AmirEnglund
- Article Feed
- Joined
